StockSelector.com
  Research, Select, & Monitor Thursday, October 24, 2019 12:03:29 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Novavax, Inc.$4.30($.04)(.92%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Novavax, Inc. has an overall rank of 6940 out of 7140 stocks based on 4 positive rankings and 9 negative rankings.

Positive Rankings
Target Prices
The average analysts' target price is $17.00 for Novavax using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Novavax is ranked 20.
Low Put/Call
Novavax has a low Put/Call ratio of 0.11 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Novavax is ranked 265.
Oversold Stochastics
Novavax rank is 350
Historic Revenue Growth
Novavax rank is 1341
Negative Rankings
Negative Revenue Estimate
Novavax rank is 31
Down EPS Surprise
Novavax missed the consensus earnings estimate when it last reported quarterly earnings.
Negative Net Margin
Novavax rank is 209
Negative ROA
Novavax rank is 316
10 Day Loss
Novavax rank is 419
Negative Cash Growth
Novavax rank is 774
High vPut/Call
Novavax has a high Put/Call ratio of 2.09 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Novavax is ranked 906.
Price-to-Sales
Novavax rank is 1093
90 Day Loss
Novavax rank is 1154







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.